Ipca Laboratories Ltd.
Ipca Laboratories PresentationJune 2018Company OverviewIncorporation:1949Present Management :Since 1975Total income F. Y. 2017-18:` Crs / US$ 505 MnExports F. Y. 2017-18:` Crs / US$ 243 MnExports F. Y. 2017-18:` Crs / US$ 243 MnNumber of Employees:13,294 including 6131in marketing and distributionBusiness Model:Fully integrated pharmaceuticalcompany producing Brandedand Generics Formulations,APIs and IntermediatesFive Years Highlights2013-14 2014-15 2015-16 2016-17 2017-18Domestic Income ( ` Crs )1, , , , , Income (US $ Mn) Income ( ` Crs )2, , , , , Income ( ` Crs )2, , , , , Income (US $ Mn) Income ( ` Crs )3, , , , , Income (US $ Mn) Profit After Tax ( ` Crs ) Profit After Tax (US $ Mn) Faciliti
International APIs –Drug Master Files Sr. No. Name of the API US- FDA Canada- HPFB WHO Japan - PMDA Australia EDQM 1 Atenolol aaaa a aaa a aaa CEP aaaa 2 Artemether aaaa a aaa 3 Artesunate aaaa 4 Artesunate Sterile aaaa 5 Amodiaquine Hcl aaaa 6 Amlodipine Besylate aaaa aaaa 7 Allopurinol aaaa a aaa CEP aaaa 8 Beventalol Hcl aaaa 9 Benzarone aaaa 10 Benzbromarone aaaa 11 …
Download Ipca Laboratories Ltd.
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: